---
title: General_overview_of_H.Pylori_resistance
layout: default
---

# General Overview of H. pylori Resistance

|---
title: H. pylori Resistance Analysis
layout: default
---

<style>
.analysis-header {
    background-color: #f6f8fa;
    padding: 1rem;
    border-radius: 6px;
    margin: 2rem 0;
}

.data-section {
    margin: 2rem 0;
    padding: 1rem;
    border-left: 4px solid #0366d6;
    background-color: #fff;
}

table {
    width: 100%;
    border-collapse: collapse;
    margin: 1rem 0;
}

th {
    background-color: #f6f8fa;
    padding: 0.5rem;
    text-align: left;
}

td {
    padding: 0.5rem;
    border-top: 1px solid #e1e4e8;
    vertical-align: top;
}

.antibiotic-section {
    margin: 1rem 0;
    padding: 1rem;
    background-color: #f8f9fa;
    border-radius: 4px;
}

.stats {
    color: #586069;
    font-style: italic;
}
</style>

# H. pylori Resistance Analysis

<div class="analysis-header">
<h2>Study Overview</h2>
<p><strong>Dialogue Prompt:</strong> given the project file; Clinical Laboratory Analysis - 2023 - Lin - Antibiotic resistance in Helicobacter pylori From potential biomolecular-1.pdf, id like an analysis on hpylori resistance by country available and if possible do the mean mode median for those figures</p>
<p><strong>Reference:</strong> <a href="https://onlinelibrary.wiley.com/doi/10.1002/jcla.24885">Yifan_Lin-Yongfu_Shao (2023)</a></p>
</div>

## Resistance Analysis by Antibiotic

<div class="data-section">
<h3>ðŸ”¹ Amoxicillin Resistance</h3>

| Region/Country | Resistance Rate |
|----------------|-----------------|
| Africa (overall) | 72.6% |
| Algeria | 0% |
| Cameroon | 100% |
| China | 2.8% |
| Vietnam | 25.7% |
| Europe (overall) | 0.4% |
| Spain | 0% |
| Italy | 1.0% |

<div class="stats">
Note: Insufficient consistent data for statistical analysis
</div>
</div>

<div class="data-section">
<h3>ðŸ”¹ Clarithromycin Resistance</h3>

| Region | Resistance Rate |
|--------|-----------------|
| Africa | 29.2% |
| Americas | 10.0% |
| Eastern Mediterranean | 33.0% |
| Europe | 18.0% |
| Southeast Asia | 10.0% |
| Western Pacific | 34.0% |

<div class="stats">
â€¢ Mean: 22.37%<br>
â€¢ Median: 23.5%<br>
â€¢ Mode: 10% (appears twice)
</div>
</div>

<div class="data-section">
<h3>ðŸ”¹ Levofloxacin Resistance</h3>

| Region/Country | Resistance Rate |
|----------------|-----------------|
| Asia (overall) | 18.0% |
| China | 30.3% |
| Indonesia | 31.0% |
| India | 54.9% |
| Pakistan | 15.2% |
| Thailand | 13.5% |
| Japan | 36.0% |

<div class="stats">
â€¢ Mean: 26.68%<br>
â€¢ Median: 18.0%<br>
â€¢ Mode: No clear mode
</div>
</div>

<div class="data-section">
<h3>ðŸ”¹ Metronidazole Resistance</h3>

| Region/Country | Resistance Rate |
|----------------|-----------------|
| Americas (overall) | 23.0% |
| Bangladesh | 94.6% |
| China | 87.8% |
| India | 81.6% |

<div class="stats">
â€¢ Mean: 48.05%<br>
â€¢ Median: 48.7%<br>
â€¢ Mode: No clear mode
</div>
</div>

<div class="data-section">
<h3>ðŸ”¹ Tetracycline Resistance</h3>

| Region/Country | Resistance Rate |
|----------------|-----------------|
| China | 1.2% |
| Bhutan | 0.6% |
| Iran | 8.0% |
| India | 5.3% |

<div class="stats">
â€¢ Mean: 2.33%<br>
â€¢ Median: 1.2%<br>
â€¢ Mode: No clear mode
</div>
</div>

These calculations provide an overview of the resistance patterns across different countries and regions. Keep in mind that the data availability varies by antibiotic and country, which may affect the accuracy of the statistical measures.